Calidi Biotherapeutics (CLDI) Receivables - Net (2022 - 2025)
Calidi Biotherapeutics (CLDI) posted quarterly Receivables - Net of $50.0 billion for Q4 2025, up 24999900.0% year-over-year from N/an in Q4 2024, and up 99999900.0% quarter-over-quarter from $50000.0 in Q2 2025.
Calidi Biotherapeutics (CLDI) Receivables - Net (2022 - 2025) Analysis & Trends
Calidi Biotherapeutics' Receivables - Net history runs 4 years deep, the most recent figure standing at $50.0 billion for Q4 2025.
- In Q4 2025, Receivables - Net rose 24999900.0% year-over-year to $50.0 billion; the TTM figure through Dec 2025 stood at $50.0 billion (up 24999900.0% YoY), while the FY2025 annual figure was $50.0 billion, up 24999900.0% from the prior year.
- Receivables - Net for Q4 2025 stood at $50.0 billion, up from $50000.0 in the prior quarter.
- The five-year high for Receivables - Net was $50.0 billion in Q4 2025, with the low at $870.0 in Q4 2022.
- The 4-year median for Receivables - Net is $125000.0 (2024), against an average of $6.3 billion.
- The sharpest annual moves came in 2024 and 2025: Receivables - Net tumbled 93.1% in 2024, then soared 24999900.0% in 2025.
- Calidi Biotherapeutics' Receivables - Net stood at $870.0 in 2022, then jumped by 333233.33% to $2.9 million in 2023, then sank by 93.1% to $200000.0 in 2024, then jumped by 24999900.0% to $50.0 billion in 2025.
- Business Quant data shows CLDI's Receivables - Net at $50.0 billion in Q4 2025, $50000.0 in Q2 2025, and $50000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Calidi Biotherapeutics | 1.88 Mn | -2.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 50.00 Bn |
| Dec 31, 2025 | 50.00 Bn |
| Jun 30, 2025 | 50,000.00 |
| Jun 30, 2025 | 50,000.00 |
| Mar 31, 2025 | 50,000.00 |
| Mar 31, 2025 | 50,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Dec 31, 2023 | 2.90 Mn |
| Dec 31, 2023 | 2.90 Mn |
| Jun 30, 2023 | 870.00 |
| Jun 30, 2023 | 870.00 |
| Dec 31, 2022 | 870.00 |
| Dec 31, 2022 | 870.00 |